1. Home
  2. SRTA vs RGNX Comparison

SRTA vs RGNX Comparison

Compare SRTA & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

HOLD

Current Price

$5.11

Market Cap

530.4M

Sector

N/A

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$9.64

Market Cap

528.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRTA
RGNX
Founded
2014
2008
Country
United States
United States
Employees
601
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
530.4M
528.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SRTA
RGNX
Price
$5.11
$9.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$7.81
$28.75
AVG Volume (30 Days)
1.3M
2.9M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
N/A
$10,393,000.00
Revenue This Year
$39.27
$51.21
Revenue Next Year
$8.52
$19.08
P/E Ratio
$9.88
N/A
Revenue Growth
N/A
126.48
52 Week Low
$3.85
$5.46
52 Week High
$6.50
$16.19

Technical Indicators

Market Signals
Indicator
SRTA
RGNX
Relative Strength Index (RSI) 42.35 41.77
Support Level $4.76 $7.84
Resistance Level $5.16 $10.56
Average True Range (ATR) 0.22 1.24
MACD -0.00 -0.48
Stochastic Oscillator 17.86 17.56

Price Performance

Historical Comparison
SRTA
RGNX

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: